Dr Maurie Markman discusses survey results indicating that patients may be interested in flexible dosing options.
Professor of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center; President, Medicine & Science, City of Hope Atlanta, Chicago, PhoenixHello. I'm Dr Maurie Markman, from City of Hope. I'd like to talk about an absolutely fascinating paper that recently appeared in
This is a very interesting analysis. This organization of patient advocates and medical oncologists, the Patient-Centered Dosing Initiative, conducted a survey of women with metastatic breast cancer regarding the patients' treatment-related side effects. There were 1221 patients with metastatic breast cancer who completed the survey.
The question was asked about dosing. Now, these are women who obviously received therapy for their metastatic breast cancer, and 53% stated that they did not believe that higher doses are always more effective than lower doses. Most important, 92% of those surveyed said they were willing to discuss flexible dosing options with their oncologist based on personal characteristics and quality-of-life considerations.
What this survey suggests is that, obviously, patients don't reject that in any way, shape, or form. Perhaps when you then add in the risks, some patients may say,"But if you lower the dose, would that risk be lower to me? Maybe that would be something that I would be interested in considering."
Metastatic Breast Carcinoma Metastatic Breast Cancer MBC Mbc Advanced BC Metastatic BC Metastatic Breast Cancer (MBC) MBC - Metastatic Breast Cancer Patient Safety Toxicology Toxicity Poisoning Toxins Breast Cancer Malignant Breast Neoplasm Breast Carcinoma Breast Mammary Gland Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Adverse Effects
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Breast Medical Oncology - Houston, Texas (US) job with The University of Texas MD Anderson Cancer CenterPostdoctoral Fellow Position Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center A postdoctoral position is available immediately in the laboratory of Dr. Chandra Bartholomeusz in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center.
Read more »
East meets West: How integrative oncology is saving livesFor centuries, eastern and western medicines have operated in separate spheres. But now a new approach to healthcare is taking root — merging the two philosophies by using the ancient practice of Chinese medicine to enhance modern treatments.
Read more »
Montana Hospital to Pay $10.8M to Settle False Claims Oncology SuitSeparately, oncologist Thomas Weiner, a former employee, also faces a civil suit, which alleges he overbilled the government for cancer services and overprescribed medications, among other claims.
Read more »
Assessing the Impact of FDA Accelerated Approval in OncologyDr Maurie Markman discusses beneficial outcomes of the FDA Accelerated Approval Program based on surrogate models.
Read more »
Jeffrey Weber, MD, PhD, Giant of Cancer Care, DiesWeber was a pioneer in cancer immunotherapy and melanoma research and a valued Medscape Oncology contributor.
Read more »
Case Dismissed: No Cancer Drug Delivery to Patients' HomesLast year, the Community Oncology Alliance sued to reverse a policy that prohibits oncology practices from mailing cancer drugs to patients at home. A judge recently dismissed the suit.
Read more »